Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease characterized by progressive scarring of lung ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

The following is a summary of “Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

One medical institution has issued a health warning on social media about the incurable lung condition that late BBC DJ ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as ...

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

EMBL scientists uncover potential use of an FDA-approved over-the-counter cough syrup ingredient to treat fibrotic lung ...

A 68-year-old Naples man is walking 106 miles through the Florida Keys to raise awareness about a life-threatening lung ...

CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct clinical trials in China of SYH-2059 tablets for interstitial lung disease ...